Autophagosome-derived exosomes obtained from malignant effusions of cancer patients could activate the differentiation of human B cells into IL-10-producing B cells with immunomodulatory activities, with the level positively correlating with HMGB1 expression on tumor cell-released autophagosomes [133]. The gene discussed is HMGB1; the disease is cancer.